Dorchester Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.8M | Sell |
294,077
-235
| -0.1% | -$6.37K | 1.56% | 22 |
|
|
2024
Q3 | $8.52M | Buy |
294,312
+12,690
| +5% | +$370K | 1.55% | 23 |
|
|
2024
Q2 | $7.88M | Sell |
281,622
-10,035
| -3% | -$276K | 1.52% | 23 |
|
|
2024
Q1 | $8.09M | Buy |
291,657
+50,565
| +21% | +$1.4M | 1.46% | 28 |
|
|
2023
Q4 | $6.94M | Buy |
241,092
+7,305
| +3% | +$221K | 1.28% | 28 |
|
|
2023
Q3 | $7.75M | Buy |
233,787
+7,390
| +3% | +$261K | 1.57% | 23 |
|
|
2023
Q2 | $8.3M | Buy |
226,397
+5,150
| +2% | +$200K | 1.69% | 21 |
|
|
2023
Q1 | $9.03M | Buy |
221,247
+38,729
| +21% | +$1.67M | 1.86% | 17 |
|
|
2022
Q4 | $9.35M | Sell |
182,518
-35,897
| -16% | -$1.72M | 2.21% | 13 |
|
|
2022
Q3 | $9.56M | Buy |
218,415
+2,720
| +1% | +$132K | 2.11% | 12 |
|
|
2022
Q2 | $11.3M | Sell |
215,695
-182
| -0.1% | -$9.28K | 2.25% | 11 |
|
|
2022
Q1 | $14M | Buy |
215,877
+445
| +0.2% | +$23.1K | 2.24% | 10 |
|
|
2021
Q4 | $12.7M | Buy |
215,432
+1,910
| +0.9% | +$94.6K | 2.52% | 9 |
|
|
2021
Q3 | $9.18M | Buy |
213,522
+3,615
| +2% | +$160K | 2.26% | 13 |
|
|
2021
Q2 | $8.22M | Buy |
209,907
+4,455
| +2% | +$173K | 1.88% | 17 |
|
|
2021
Q1 | $7.44M | Buy |
205,452
+10,062
| +5% | +$357K | 1.85% | 19 |
|
|
2020
Q4 | $7.19M | Buy |
195,390
+42,380
| +28% | +$1.55M | 1.9% | 17 |
|
|
2020
Q3 | $5.33M | Sell |
153,010
-535
| -0.3% | -$18.8K | 1.65% | 21 |
|
|
2020
Q2 | $4.76M | Sell |
153,545
-146
| -0.1% | -$4.96K | 1.51% | 23 |
|
|
2020
Q1 | $4.76M | Sell |
153,691
-3,642
| -2% | -$124K | 1.76% | 21 |
|
|
2019
Q4 | $5.85M | Buy |
157,333
+464
| +0.3% | +$16.5K | 1.63% | 23 |
|
|
2019
Q3 | $5.35M | Buy |
156,869
+1,887
| +1% | +$68.6K | 1.57% | 22 |
|
|
2019
Q2 | $6.37M | Buy |
154,982
+7,531
| +5% | +$299K | 1.89% | 18 |
|
|
2019
Q1 | $5.94M | Sell |
147,451
-35,685
| -19% | -$1.43M | 1.81% | 18 |
|
|
2018
Q4 | $7.58M | Buy |
183,136
+5,484
| +3% | +$228K | 2.64% | 12 |
|
|
2018
Q3 | $7.43M | Sell |
177,652
-448
| -0.3% | -$17.2K | 2.31% | 14 |
|
|
2018
Q2 | $6.13M | Sell |
178,100
-2,182
| -1% | -$74.6K | 2.02% | 17 |
|
|
2018
Q1 | $6.07M | Buy |
180,282
+14,735
| +9% | +$507K | 2.04% | 17 |
|
|
2017
Q4 | $5.69M | Sell |
165,547
-515
| -0.3% | -$17.6K | 1.8% | 17 |
|
|
2017
Q3 | $5.63M | Buy |
166,062
+6,852
| +4% | +$220K | 1.81% | 18 |
|
|
2017
Q2 | $5.07M | Buy |
159,210
+4,128
| +3% | +$130K | 1.75% | 18 |
|
|
2017
Q1 | $5.03M | Sell |
155,082
-453
| -0.3% | -$14.3K | 1.75% | 18 |
|
|
2016
Q4 | $4.79M | Buy |
155,535
+1,403
| +0.9% | +$42.8K | 1.75% | 19 |
|
|
2016
Q3 | $4.95M | Buy |
154,132
+26,014
| +20% | +$870K | 1.84% | 19 |
|
|
2016
Q2 | $4.28M | Sell |
128,118
-43,561
| -25% | -$1.39M | 1.59% | 21 |
|
|
2016
Q1 | $4.83M | Buy |
171,679
+407
| +0.2% | +$11.6K | 1.83% | 20 |
|
|
2015
Q4 | $5.25M | Sell |
171,272
-1,026
| -0.6% | -$32.3K | 2.18% | 15 |
|
|
2015
Q3 | $6.85M | Sell |
172,298
-3,277
| -2% | -$105K | 2.53% | 11 |
|
|
2015
Q2 | $6.98M | Buy |
+175,575
| New | +$5.72M | 2.3% | 12 |
|
Other funds holding PFE
Dorchester Wealth Management's PFE Position: Q4 2024 in Review
Dorchester Wealth Management reduced its Pfizer (PFE) stake by 0.08% in Q4 2024, selling an estimated $6.37K and leaving 294,077 shares worth $7.8M. The position accounts for 1.56% of the portfolio, ranked #22.
Dorchester Wealth Management first reported a position in PFE in Q2 2015 and has held it in 39 quarters since. The position peaked at $14M in Q1 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Dorchester Wealth Management held 294,077 shares of Pfizer worth $7.8M as of Q4 2024.
- Dorchester Wealth Management sold 235 Pfizer shares in Q4 2024, an estimated $6.37K.
- Pfizer made up 1.56% of Dorchester Wealth Management's portfolio in Q4 2024, its #22 holding.
- Dorchester Wealth Management first reported a position in Pfizer in Q2 2015 and has held it in 39 quarters since.
- Dorchester Wealth Management's Pfizer position peaked at $14M in Q1 2022.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.